Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02356198 · ClinicalTrials.gov registry record · NA

Exparel Transversus Abdominis Plane Block vs Intrathecal Analgesia In Colorectal Surgery

A NA study, sponsored by Mayo Clinic.

Completed
Registry status
NA
Development phase
209
Enrollment target

NCT02356198: Completed NA study, sponsored by Mayo Clinic.

NCT02356198 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 209 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT02356198, a NA study, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
NA
Development phase
209 participants
Enrollment target

Study Summary

This study is prospective, randomized trial in which EXPAREL TAP block is compared to standard IT opioid administration, in relieving postoperative pain, decreasing length of stay, and use of narcotic medication.

Primary Outcome

Postoperative mean pain score for 48 hours after surgery. Pain was assessed on a 0 to 10 point visual analog scale (VAS), with 0 indicating no pain and 10 indicating severe pain. The mean pain score was summarized as the area under the curve (AUC) of the observed pain score, normalized for the total time of observation.

Interventions

  • DRUG EXPAREL
  • DRUG Intrathecal hydromorphone

Trial Details

FieldValue
Enrollment Target 209 participants
Start Date 2015-03
Est. Completion 2017-10
Phase NA
Mayo Clinic

2,844 total trials

What the finished NCT02356198 record still lists

NCT02356198 is an interventional study that assigns participants to a tested intervention. The registered 209 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower).

The record links to 0 conditions, and to 2 interventions - of which EXPAREL is the first listed.

NCT02356198 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02356198 about?

NCT02356198 is a clinical study titled "Exparel Transversus Abdominis Plane Block vs Intrathecal Analgesia In Colorectal Surgery". This study is prospective, randomized trial in which EXPAREL TAP block is compared to standard IT opioid administration, in relieving postoperative pain, decreasing length of stay, and use of narcotic medication.

What is the current status of trial NCT02356198?

This trial is currently completed. It is a NA study. The enrollment target is 209 participants. The study started on 2015-03. Estimated completion is 2017-10.

What interventions are being tested in trial NCT02356198?

The interventions under investigation include: EXPAREL (DRUG), Intrathecal hydromorphone (DRUG).

Who is sponsoring clinical trial NCT02356198?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02356198's enrollment target sits among peer trials

209 496th of 2000 higher than 1,505 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04742634 · 209 participants · Phase 1

    Pre-emptive Therapy With DEC-C to Improve Outcomes in MDS Patients With Measurable Residual Disease Post Allogeneic Hematopoietic Cell Transplant

  • NCT07214688 · 209 participants · Phase 2

    Fludarabine and Intermediate-dose TBI Followed by PTCy in Patients Undergoing Allo Transplant for Heme Malignancies

  • NCT02665923 · 210 participants

    Gastric Emptying in Neonates and Infants After Formula Feeding

  • NCT03322891 · 210 participants · NA

    Improving Health Literacy in African-American Prostate Cancer Patients

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02356198, the US trial registry maintained by the National Library of Medicine. NCT02356198 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.